黑色素瘤
单核苷酸多态性
基因座(遗传学)
SNP公司
生物
遗传学
等位基因
外显子组测序
CDKN2A
遗传变异
癌症研究
基因型
突变
基因
作者
Agnès Bourillon,Hui‐Han Hu,Gilles Hetet,J Lacapère,Jocelyne André,V. Descamps,Nicole Basset‐Séguin,Zighereda Ogbah,Susana Puig,Philippe Saïag,Martine Bagot,Armand Bensussan,Bernard Grandchamp,Nicolas Dumaz,Nadem Soufir
摘要
Summary As loss of KIT frequently occurs in melanoma progression, we hypothesized that KIT is implicated in predisposition to melanoma ( MM ). Thus, we sequenced the KIT coding region in 112 familial MM cases and 143 matched controls and genotyped tag single‐nucleotide polymorphisms ( SNP s) in two cohorts of melanoma patients and matched controls. Five rare KIT substitutions, all predicted possibly or probably deleterious, were identified in five patients, but none in controls [ RR = 2.26 (1.26–2.26)]. Expressed in melanocyte lines, three substitutions inhibited KIT signaling. Comparison with exomes database (7020 alleles) confirmed a significant excess of rare deleterious KIT substitutions in patients. Additionally, a common SNP , rs2237028, was associated with MM risk, and 6 KIT variants were associated with nevus count. Our data strongly suggest that rare KIT substitutions predispose to melanoma and that common variants at KIT locus may also impact nevus count and melanoma risk.
科研通智能强力驱动
Strongly Powered by AbleSci AI